Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cellular Differentiation00:57

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tranexamic acid inhibits group A streptococci-mediated fibrinolysis <i>in vitro</i> and modulates host immune cells <i>in vivo</i>.

Frontiers in immunology·2025
Same author

Cardiotoxicity of Metal Implant Wear: Emerging Insights into the Roles of Cobalt and Chromium.

Tissue engineering. Part B, Reviews·2025
Same author

When can we see micromotion? Experimental and theoretical analysis of the ChiSCAT scheme.

Applied optics·2025
Same author

[<sup>68</sup>Ga]Ga-NODAGA-RGD post MI reflects activated fibroblasts rather than angiogenesis.

European journal of nuclear medicine and molecular imaging·2025
Same author

Comparison of Myocardial Function in Young and Old Mice During Acute Myocardial Infarction: A Cardiac Magnetic Resonance Study.

Diagnostics (Basel, Switzerland)·2025
Same author

Exploring Peripheral and Cardiac Immune Responses in a Pneumosepsis Mouse Model with Group A <i>Streptococcus</i>.

American journal of respiratory cell and molecular biology·2025

Related Experiment Video

Updated: May 21, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

From pluripotency to distinct cardiomyocyte subtypes.

Robert David1, Wolfgang-Michael Franz

  • 11st Medical Department, University of Munich, Campus Grosshadern, Munich, Germany.

Physiology (Bethesda, Md.)
|June 13, 2012
PubMed
Summary

Adult heart cells cannot regenerate, leading to heart disease. Direct reprogramming of fibroblasts into cardiomyocytes offers a promising, potentially safer alternative to stem cell therapies for cardiac repair.

More Related Videos

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
08:52

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2

Published on: March 10, 2016

Related Experiment Videos

Last Updated: May 21, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
08:52

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2

Published on: March 10, 2016

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Stem cell science

Background:

  • Differentiated adult cardiomyocytes (CMs) exhibit limited regenerative capacity, contributing to high mortality from degenerative heart diseases.
  • Stem cell-based therapies are being explored as alternatives to heart transplantation for cardiac repair.
  • Induced pluripotent stem cells (iPSCs) offer an autologous, ethically sound alternative to embryonic stem stem cells (ESCs), but face clinical hurdles due to reprogramming-induced aberrations.

Purpose of the Study:

  • To review recent advancements in cardiovascular stem cell research.
  • To discuss the potential of direct reprogramming methods for cardiac regeneration.
  • To highlight progress in generating specific cardiovascular cell subtypes.

Main Methods:

  • Review of current literature on stem cell biology and cardiac repair.
  • Analysis of direct reprogramming techniques bypassing the pluripotent state.
  • Examination of methods for generating specific cardiovascular cell subtypes.

Main Results:

  • Direct reprogramming of fibroblasts into cardiomyocytes presents a potentially more viable clinical approach than iPSC technology.
  • Early success in generating specific cardiovascular cell subtypes has been achieved.
  • The field is progressing towards more efficient and safer cardiac regenerative strategies.

Conclusions:

  • Direct reprogramming offers a promising avenue for cardiac repair, circumventing the risks associated with iPSC generation.
  • Generating specific cardiovascular cell subtypes is crucial for future clinical applications.
  • Continued research in cardiovascular stem cell biology is vital for addressing degenerative heart diseases.